Ekso Bionics announces $4.6M registered direct offering

Ekso Bionics Holdings ( NASDAQ: EKSO ) on Thursday announced that it has entered into a securities purchase agreement with certain institutional investors for the purchase and sale of 2.97M shares of common stock at a purchase price of $1.55 per share pursuant to a registered direct offering, resulting in total gross proceeds of about $4.6 million.

EKSO 19.72% premarket to $1.73. The closing of the offering is expected to occur on or about January 16, 2024. The company intends to use the net proceeds from the offering for working capital and general corporate purposes. Source: Press Release More on Ekso Bionics Holdings Seeking Alpha’s Quant Rating on Ekso Bionics Holdings Historical earnings data for Ekso Bionics Holdings Financial information for Ekso Bionics Holdings.